Aemetis, Inc. (NASDAQ:AMTX) Sees Significant Increase in Short Interest

Aemetis, Inc. (NASDAQ:AMTX) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 5,670,000 shares, an increase of 5.8% from the November 30th total of 5,360,000 shares. Based on an average daily volume of 729,000 shares, the short-interest ratio is presently 7.8 days.

Hedge Funds Weigh In On Aemetis

Hedge funds have recently bought and sold shares of the company. Barclays PLC grew its holdings in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the period. Geode Capital Management LLC boosted its position in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares in the last quarter. Wellington Management Group LLP acquired a new stake in Aemetis during the third quarter worth approximately $177,000. State Street Corp lifted its stake in Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares during the period. Finally, FMR LLC boosted its holdings in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares in the last quarter. Institutional investors own 27.02% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on AMTX shares. StockNews.com raised Aemetis to a “sell” rating in a research note on Wednesday, December 25th. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Trading Up 4.8 %

NASDAQ AMTX opened at $2.82 on Friday. The firm has a market capitalization of $140.25 million, a PE ratio of -1.25 and a beta of 1.35. The business’s 50-day moving average price is $3.27 and its two-hundred day moving average price is $2.98. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the company earned ($0.59) earnings per share. As a group, analysts forecast that Aemetis will post -2.02 earnings per share for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.